ARCHIVES

FDA Auditors Spend Two Weeks At Duke, Nevins Loses Position in Reorganization

This article is from The Cancer Letter archive.

Vol. 37 No. 04 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

DCCPT Board, NCAB Approve Core Grant Guideline Changes, Consortium Centers

May 17, 1985

Report on Carcinogens: Advisors Recommend Tobacco, UV Light, Tamoxifen, For Report

November 7, 1997

Volasertib Shows Response In 31 Percent of Acute Myeloid Leukemia Patients

December 28, 2012

House Committee Seeks Review Of Indirect Costs Of NIH Grantees

July 25, 2013

In Breif: FDA Issues Uterine Cancer-Tamoxifin Warning; Fisher Declined Invitation To Speak At AACR

April 15, 1994

Promising Results For Glivec In CML Continue, FDA Grants Priority Review

April 27, 2001